Author: <span>Walter Pacheco</span>
immunotherapy clinical trial, immunotherapy for cancer, mesothelioma, mesothelioma clinical trials, mesothelioma immunotherapy, Mesothelioma News, ONCOS 102

ONCOS-102 Mesothelioma Clinical Trial Promises Hope

 

Scandinavian-based Targovax launched the latest immunotherapy clinical trial for pleural mesothelioma, hoping it delivers a better way to treat patients with asbestos-related diseases. The randomized phase Ib/II trial evaluates the performance of ONCOS-102, an engineered human adenovirus designed to induce systemic, anti-tumor responses. Researchers are administering the immunotherapy drug as first-line therapy in combination with…

The post ONCOS-102 Mesothelioma Clinical Trial Promises Hope appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

immunotherapy clinical trial, immunotherapy for cancer, mesothelioma, mesothelioma clinical trials, mesothelioma immunotherapy, Mesothelioma News, ONCOS 102

ONCOS-102 Mesothelioma Clinical Trial Promises Hope

 

Scandinavian-based Targovax launched the latest immunotherapy clinical trial for pleural mesothelioma, hoping it delivers a better way to treat patients with asbestos-related diseases. The randomized phase Ib/II trial evaluates the performance of ONCOS-102, an engineered human adenovirus designed to induce systemic, anti-tumor responses. Researchers are administering the immunotherapy drug as first-line therapy in combination with…

The post ONCOS-102 Mesothelioma Clinical Trial Promises Hope appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

activin A, Asbestos Cancer, asbestos diseases, Balazs Hegedus, cancer treatment, mesothelioma, mesothelioma biomarker, mesothelioma blood biomarker, Mesothelioma News, Mesothelioma Research, multimodal cancer therapy, treatments for mesothelioma

Researchers Discover New Mesothelioma Blood Biomarker

 

An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,…

The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

activin A, Asbestos Cancer, asbestos diseases, Balazs Hegedus, cancer treatment, mesothelioma, mesothelioma biomarker, mesothelioma blood biomarker, Mesothelioma News, Mesothelioma Research, multimodal cancer therapy, treatments for mesothelioma

Researchers Discover New Mesothelioma Blood Biomarker

 

An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,…

The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

activin A, Asbestos Cancer, asbestos diseases, Balazs Hegedus, cancer treatment, mesothelioma, mesothelioma biomarker, mesothelioma blood biomarker, Mesothelioma News, Mesothelioma Research, multimodal cancer therapy, treatments for mesothelioma

Researchers Discover New Mesothelioma Blood Biomarker

 

An international team of scientists recently identified a new blood biomarker for mesothelioma that should help with early diagnosis, prognosis accuracy and the personalization of treatment. Researchers identified activin A, a protein complex found in the blood, as a potential target for future therapies. “Blood derived biomarkers are important because they can be noninvasively measured,…

The post Researchers Discover New Mesothelioma Blood Biomarker appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos related to kidney cancer, cancer research, kidney cancer, mesothelioma, Mesothelioma News, peritoneal mesothelioma

New Study: Asbestos Related to Most Common Kidney Cancer

 

Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful…

The post New Study: Asbestos Related to Most Common Kidney Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos related to kidney cancer, cancer research, kidney cancer, mesothelioma, Mesothelioma News, peritoneal mesothelioma

New Study: Asbestos Related to Most Common Kidney Cancer

 

Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful…

The post New Study: Asbestos Related to Most Common Kidney Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos related to kidney cancer, cancer research, kidney cancer, mesothelioma, Mesothelioma News, peritoneal mesothelioma

New Study: Asbestos Related to Most Common Kidney Cancer

 

Exposure to asbestos may lead to renal cell carcinoma, the most common type of kidney cancer, an Italian study shows. The link to kidney cancer adds to the horrific history of asbestos, a substance definitively recognized as a cause of mesothelioma, lung cancer and a variety of other respiratory illnesses. In the past, a handful…

The post New Study: Asbestos Related to Most Common Kidney Cancer appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos in canada, asbestos in canada construction, asbestos in canada homes, asbestos related cancers, canadian asbestos epidemic, mesothelioma, Mesothelioma News, work related asbestos exposure

Asbestos-Related Cancers Cost Canada $2B Annually

 

The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic…

The post Asbestos-Related Cancers Cost Canada $2B Annually appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos in canada, asbestos in canada construction, asbestos in canada homes, asbestos related cancers, canadian asbestos epidemic, mesothelioma, Mesothelioma News, work related asbestos exposure

Asbestos-Related Cancers Cost Canada $2B Annually

 

The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic…

The post Asbestos-Related Cancers Cost Canada $2B Annually appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos Cancer, asbestos in canada, asbestos in canada construction, asbestos in canada homes, asbestos related cancers, canadian asbestos epidemic, mesothelioma, Mesothelioma News, work related asbestos exposure

Asbestos-Related Cancers Cost Canada $2B Annually

 

The Canadian government spends about $1.7 billion annually on asbestos-related cancers stemming from occupational exposure, according to a recent Institute for Work & Health study. Researchers included the costs of treating mesothelioma and asbestos-related lung cancer, administration expenses, patients’ out-of-pocket costs, caregiving wages, workers’ compensation and employers’ costs to replace absent workers, among other economic…

The post Asbestos-Related Cancers Cost Canada $2B Annually appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos / Mesothelioma, asbestos ban, Asbestos Cancer, banning asbestos, Mesothelioma News, national ban on asbestos, new zealand asbestos ban

New Zealand Enacts National Asbestos Ban

 

New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of…

The post New Zealand Enacts National Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos / Mesothelioma, asbestos ban, Asbestos Cancer, banning asbestos, Mesothelioma News, national ban on asbestos, new zealand asbestos ban

New Zealand Enacts National Asbestos Ban

 

New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of…

The post New Zealand Enacts National Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Asbestos / Mesothelioma, asbestos ban, Asbestos Cancer, banning asbestos, Mesothelioma News, national ban on asbestos, new zealand asbestos ban

New Zealand Enacts National Asbestos Ban

 

New Zealand will prohibit importation of all asbestos products and materials beginning Oct. 1, joining 57 other countries that already ban asbestos. Nick Smith, New Zealand environment minister, announced the latest prohibition last week. His statement marked progress toward a long-sought, worldwide ban on the toxic mineral. “It’s about bloody time,” Laurie Kazan-Allen, coordinator of…

The post New Zealand Enacts National Asbestos Ban appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

clinical trial, Immunotherapy, immunotherapy clinical trial, immunotherapy for mesothelioma, Mesothelioma News, Mesothelioma Research, Mesothelioma treatment, raffitt hassan

Immunotherapy Trial for Mesothelioma Shows Early Promise

 

The immunotherapy drug avelumab showed promising results in a recent phase I clinical trial for malignant mesothelioma, raising hopes as a future second-line therapy. The clinical trial included 53 patients with pleural or peritoneal mesothelioma. It was part of the JAVELIN development program for avelumab, a series of clinical studies testing the drug on about…

The post Immunotherapy Trial for Mesothelioma Shows Early Promise appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.